TY - JOUR
T1 - A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)
AU - Thomas, Gilles
AU - Jacobs, Kevin B
AU - Kraft, Peter
AU - Yeager, Meredith
AU - Wacholder, Sholom
AU - Cox, David G
AU - Hankinson, Susan E
AU - Hutchinson, Amy
AU - Wang, Zhaoming
AU - Yu, Kai
AU - Chatterjee, Nilanjan
AU - Garcia-Closas, Montserrat
AU - Gonzalez-Bosquet, Jesus
AU - Prokunina-Olsson, Ludmila
AU - Orr, Nick
AU - Willett, Walter C
AU - Colditz, Graham A
AU - Ziegler, Regina G
AU - Berg, Christine D
AU - Buys, Saundra S.
AU - McCarty, Catherine A
AU - Feigelson, Heather Spencer
AU - Calle, Eugenia E
AU - Thun, Michael J
AU - Diver, Ryan
AU - Prentice, Ross
AU - Jackson, Rebecca D
AU - Kooperberg, Charles
AU - Chlebowski, Rowan
AU - Lissowska, Jolanta
AU - Peplonska, Beata
AU - Brinton, Louise A
AU - Sigurdson, Alice
AU - Doody, Michele
AU - Bhatti, Parveen
AU - Alexander, Bruce H
AU - Buring, Julie
AU - Lee, I-Min
AU - Vatten, Lars J
AU - Hveem, Kristian
AU - Kumle, Merethe
AU - Hayes, Richard B
AU - Tucker, Margaret
AU - Gerhard, Daniela S
AU - Fraumeni, Joseph F
AU - Hoover, Robert N
AU - Chanock, Stephen J.
AU - Hunter, David J
PY - 2009/5
Y1 - 2009/5
N2 - We conducted a three-stage genome-wide association study (GWAS) of breast cancer in 9,770 cases and 10,799 controls in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative. In stage 1, we genotyped 528,173 SNPs in 1,145 cases of invasive breast cancer and 1,142 controls. In stage 2, we analyzed 24,909 top SNPs in 4,547 cases and 4,434 controls. In stage 3, we investigated 21 loci in 4,078 cases and 5,223 controls. Two new loci achieved genome-wide significance. A pericentromeric SNP on chromosome 1p11.2 (rs11249433; P = 6.74 x 10(-10) adjusted genotype test, 2 degrees of freedom) resides in a large linkage disequilibrium block neighboring NOTCH2 and FCGR1B; this signal was stronger for estrogen-receptor-positive tumors. A second SNP on chromosome 14q24.1 (rs999737; P = 1.74 x 10(-7)) localizes to RAD51L1, a gene in the homologous recombination DNA repair pathway. We also confirmed associations with loci on chromosomes 2q35, 5p12, 5q11.2, 8q24, 10q26 and 16q12.1.
AB - We conducted a three-stage genome-wide association study (GWAS) of breast cancer in 9,770 cases and 10,799 controls in the Cancer Genetic Markers of Susceptibility (CGEMS) initiative. In stage 1, we genotyped 528,173 SNPs in 1,145 cases of invasive breast cancer and 1,142 controls. In stage 2, we analyzed 24,909 top SNPs in 4,547 cases and 4,434 controls. In stage 3, we investigated 21 loci in 4,078 cases and 5,223 controls. Two new loci achieved genome-wide significance. A pericentromeric SNP on chromosome 1p11.2 (rs11249433; P = 6.74 x 10(-10) adjusted genotype test, 2 degrees of freedom) resides in a large linkage disequilibrium block neighboring NOTCH2 and FCGR1B; this signal was stronger for estrogen-receptor-positive tumors. A second SNP on chromosome 14q24.1 (rs999737; P = 1.74 x 10(-7)) localizes to RAD51L1, a gene in the homologous recombination DNA repair pathway. We also confirmed associations with loci on chromosomes 2q35, 5p12, 5q11.2, 8q24, 10q26 and 16q12.1.
KW - Alleles
KW - Breast Neoplasms
KW - Chromosomes, Human, Pair 1
KW - Chromosomes, Human, Pair 14
KW - DNA-Binding Proteins
KW - Female
KW - Genetic Predisposition to Disease
KW - Genome, Human
KW - Genome-Wide Association Study
KW - Genotype
KW - Humans
KW - Linkage Disequilibrium
KW - Polymorphism, Single Nucleotide
KW - Journal Article
KW - Research Support, N.I.H., Extramural
KW - Research Support, N.I.H., Intramural
U2 - 10.1038/ng.353
DO - 10.1038/ng.353
M3 - Article
C2 - 19330030
SN - 1061-4036
VL - 41
SP - 579
EP - 584
JO - Nature Genetics
JF - Nature Genetics
IS - 5
ER -